CPA
DMK

Clear Point Advisors’s DMK Pharmaceuticals Corporation Common Stock DMK Stock Holding History

Clear Point Advisors’s Portfolio DMK Stock Details DMK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-53
Closed -$3 – 597
2024
Q1 		$3 Hold
53
– – ﹤0.01% 572
2023
Q4 		$37 Buy
+53
New +$31 ﹤0.01% 537

Clear Point Advisors's DMK Position: Q2 2024 in Review

Clear Point Advisors sold out of DMK Pharmaceuticals Corporation Common Stock (DMK) in Q2 2024, closing a stake of 53 shares — an estimated $3 sold.

Clear Point Advisors first reported a position in DMK in Q4 2023 and held it in 2 quarters. The position peaked at $37 in Q4 2023. 2 funds tracked by Wall St. Rank hold DMK as of Q2 2024.

  • Clear Point Advisors reported no remaining DMK Pharmaceuticals Corporation Common Stock position as of Q2 2024 after selling out during the quarter.
  • Clear Point Advisors sold 53 DMK Pharmaceuticals Corporation Common Stock shares in Q2 2024, an estimated $3.
  • Clear Point Advisors first reported a position in DMK Pharmaceuticals Corporation Common Stock in Q4 2023 and held it in 2 quarters.
  • Clear Point Advisors's DMK Pharmaceuticals Corporation Common Stock position peaked at $37 in Q4 2023.
  • 2 funds tracked by Wall St. Rank held DMK Pharmaceuticals Corporation Common Stock as of Q2 2024.

Based on Clear Point Advisors's 13F filing for Q2 2024, filed 14 Aug 2024.